FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

50841000172109: Belgian subset for AllergyIntolerance, causative agent, drug (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 15-Nov 2022. Module: Belgian module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
7891641000172111 Belgian subset for AllergyIntolerance, causative agent, drug en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) Belgian module (core metadata concept)
7891651000172113 Belgian subset for AllergyIntolerance, causative agent, drug (foundation metadata concept) en Fully specified name Active Only initial character case insensitive (core metadata concept) Belgian module (core metadata concept)
7891661000172110 sous-ensemble belge pour AllergyIntolerance, agent causal, médicaments fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Belgian module (core metadata concept)
7891671000172118 Belgische subset voor AllergyIntolerance, oorzakelijk agens, medicatie nl Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) Belgian module (core metadata concept)


6399 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Belgian subset for AllergyIntolerance, causative agent, drug Is a Simple type reference set (foundation metadata concept) true Inferred relationship Some

Members
Hypnotic AND/OR sedative (substance)
Hypnotic agent (substance)
Hypotensive agent (substance)
Hypothalamic hormone (substance)
Hypothalamic releasing factor
Hypromellose (substance)
Ibacitabine (substance)
Ibalizumab (substance)
Ibandronate
Ibandronate sodium (substance)
Ibandronate sodium monohydrate
Ibandronic acid (substance)
Ibopamine (substance)
Ibopamine hydrochloride (substance)
Ibritumomab tiuxetan (substance)
Ibrutinib (substance)
Ibuprofen (substance)
Ibuprofen lysine (substance)
Ibuprofen sodium (substance)
Ibuprofen sodium dihydrate (substance)
Ibutilide (substance)
Ibutilide fumarate
Icatibant (substance)
Icatibant acetate
Iclaprim (substance)
Idarubicin (substance)
Idarubicin hydrochloride
Idarucizumab (substance)
Idebenone (substance)
Idecabtagene vicleucel (substance)
Idelalisib (substance)
Idoxuridine (substance)
Idrocilamide (substance)
Ifenprodil (substance)
Ifosfamide (substance)
Iloperidone (substance)
Iloprost (substance)
Iloprost trometamol
Imatinib (substance)
Imatinib mesilate
Imdevimab (substance)
Imidacloprid (substance)
Imidapril (substance)
Imidapril hydrochloride (substance)
Imidocarb (substance)
Imidocarb dihydrochloride
Imidocarb dipropionate
Imipenem
Imipenem anhydrous (substance)
Imipenem monohydrate (substance)
Imipramine (substance)
Imipramine hydrochloride
Imipramine pamoate
Imiquimod (substance)
Immune enhancement agent (substance)
Cytomegalovirus IgA
Cytomegalovirus IgG
Immunoglobulin M antibody to Varicella zoster virus (substance)
Immunologic agent (substance)
Immunoreactive parathormone
Immunoreactive trypsin
Immunosuppressant (substance)
Inclisiran (substance)
IncobotulinumtoxinA (substance)
Incretin (substance)
Indacaterol (substance)
Indacaterol maleate (substance)
Indanedione (substance)
Indapamide (substance)
Indapamide hemihydrate (substance)
Indecainide (substance)
Indecainide hydrochloride (substance)
Indinavir (substance)
Indinavir sulfate
Indirect acting anticoagulant (substance)
Indium (111-In) transferrin (substance)
Indobufen (substance)
Indometacin
Indometacin sodium (substance)
Indometacin sodium trihydrate
Indoramin (substance)
Indoramin hydrochloride
Inebilizumab
Infigratinib
Infliximab (substance)
Ingenol mebutate
Inhibin A (substance)
Inhibin B (substance)
Inhibin hormone
Inolimomab
Inosine pranobex (substance)
Inositol
Inositol hexanitrate
Inositol nicotinate
Inotersen (substance)
Inotersen sodium (substance)
Inotropic agent (substance)
Inotuzumab ozogamicin (substance)
Insoluble fiber (substance)
Insulin
Insulin aspart

Start Previous Page 31 of 64 Next End


Reference Sets

Reference set descriptor

Back to Start